[1]
X. Zhang, “Efficacy of Ritlecitinib (PF-06651600) in Patients With Alopecia Totalis and Alopecia Universalis: Post Hoc Analysis of the ALLEGRO Phase 2b/3 Study”, J of Skin, vol. 6, no. 6, p. s102, Nov. 2022.